Cocrystal Pharma to Present at Noble Capital Markets Emerging Growth Virtual Equity Conference
Cocrystal Pharma (Nasdaq: COCP) announces that James Martin, CFO and co-CEO, will present at the Noble Capital Markets Emerging Growth Virtual Equity Conference on October 9, 2025 at 12:00 pm Eastern time.
The presentation will include a company overview followed by a Q&A session. Investors can access the live presentation through registration, and a video webcast will be available on the company's website within 48 hours of the event, remaining accessible for 90 days. Additionally, Mr. Martin will be available for one-on-one meetings with qualified investors during the conference.
Cocrystal Pharma (Nasdaq: COCP) annuncia che James Martin, CFO e co-CEO, parteciperà a Noble Capital Markets Emerging Growth Virtual Equity Conference il 9 ottobre 2025 alle ore 12:00 ora orientale.
La presentazione comprenderà una panoramica dell’azienda seguita da una sessione di domande e risposte. Gli investitori potranno seguire la presentazione in diretta previa registrazione, e una videoregistrazione sarà disponibile sul sito dell’azienda entro 48 ore dall’evento, accessibile per 90 giorni. Inoltre, il signor Martin sarà disponibile per incontri one-to-one con investitori qualificati durante la conferenza.
Cocrystal Pharma (Nasdaq: COCP) anuncia que James Martin, director financiero y copresidente ejecutivo, presentará en la Noble Capital Markets Emerging Growth Virtual Equity Conference el 9 de octubre de 2025 a las 12:00 p.m. hora del este.
La presentación incluirá una visión general de la empresa, seguida de una sesión de preguntas y respuestas. Los inversionistas podrán acceder a la presentación en vivo mediante registro, y una videoconferencia estará disponible en el sitio web de la empresa dentro de las 48 horas posteriores al evento, y permanecerá accesible durante 90 días. Además, el Sr. Martin estará disponible para reuniones uno a uno con inversionistas calificados durante la conferencia.
Cocrystal Pharma (Nasdaq: COCP)는 제임스 마틴(CFO 겸 공동 CEO)이 Noble Capital Markets Emerging Growth Virtual Equity Conference에 2025년 10월 9일 동부 시간 12:00에 발표한다고 발표했습니다.
발표는 회사 개요와 질의응답 세션으로 구성됩니다. 투자자들은 등록을 통해 라이브 발표를 접할 수 있으며, 이벤트가 끝난 후 48시간 이내에 회사 웹사이트에서 비디오 웨스트가 제공되며 90일간 접근할 수 있습니다. 또한 마틴 씨는 컨퍼런스 기간 동안 자격을 갖춘 투자자와의 1:1 미팅을 가질 예정입니다.
Cocrystal Pharma (Nasdaq : COCP) annonce que James Martin, directeur financier et coaCEO, participera à la Noble Capital Markets Emerging Growth Virtual Equity Conference le 9 octobre 2025 à 12h00, heure de l’Est.
La présentation comprendra un aperçu de l’entreprise suivi d’une session de questions-réponses. Les investisseurs pourront accéder à la présentation en direct sur inscription, et une vidéothèque sera disponible sur le site de l’entreprise dans les 48 heures suivant l’événement et restera accessible pendant 90 jours. De plus, M. Martin sera disponible pour des réunions en tête-à-tête avec des investisseurs qualifiés pendant la conférence.
Cocrystal Pharma (Nasdaq: COCP) kündigt an, dass James Martin, CFO und Co-CEO, auf der Noble Capital Markets Emerging Growth Virtual Equity Conference am 9. Oktober 2025 um 12:00 Uhr Eastern Time auftreten wird.
Die Präsentation umfasst eine Unternehmensübersicht gefolgt von einer Fragerunde. Investoren können die Live-Präsentation nach Registrierung verfolgen, und ein Video-Webcast wird innerhalb von 48 Stunden nach der Veranstaltung auf der Website des Unternehmens verfügbar sein und dort 90 Tage lang zugänglich bleiben. Zusätzlich wird Herr Martin während der Konferenz individuelle Gespräche mit qualifizierten Investoren führen.
Cocrystal Pharma (ناسداك: COCP) تُعلن أن جيمس مارتن، المدير المالي ونائب الرئيس التنفيذي المشارك، سيقدم في Noble Capital Markets Emerging Growth Virtual Equity Conference في 9 أكتوبر 2025 الساعة 12:00 ظهرًا بتوقيت الساحل الشرقي.
سيشمل العرض لمحة عامة عن الشركة تليه جلسة أسئلة وأجوبة. يمكن للمستثمرين الوصول إلى العرض المباشر من خلال التسجيل، وسيتم توفير بث فيديو على موقع الشركة خلال 48 ساعة من الحدث وسيظل متاحًا لمدة 90 يومًا. بالإضافة إلى ذلك، سيكون السيد مارتن متاحًا للاجتماعات الفردية مع المستثمرين المؤهلين خلال المؤتمر.
Cocrystal Pharma（纳斯达克股票代码：COCP）宣布，CFO兼联席首席执行官 James Martin 将于 Noble Capital Markets Emerging Growth Virtual Equity Conference 于 2025年10月9日东部时间中午12:00 出席。
此次演示将包括公司概览，随后是问答环节。投资者可以通过注册参加现场演示，演讲将在事件后48小时内在公司网站提供视频 webcast，且可访问90天。此外，Martin先生将在会议期间与合格投资者进行一对一会谈。
- None.
- None.
BOTHELL, Wash., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that James Martin, CFO and co-CEO, will present a company overview at the Noble Capital Markets Emerging Growth Virtual Equity Conference on Thursday, October 9, 2025 at 12:00 pm Eastern time (9:00 a.m. Pacific time). The formal presentation will be followed by a hosted question-and-answer session with questions welcomed from the live virtual audience.
Those interested in viewing the live Cocrystal presentation can register for the event here. A video webcast of the presentation will be available within 48 hours following the event on the Company's website and archived for 90 days.
Mr. Martin will be available throughout the conference for virtual one-on-one meetings with registered, qualified investors. Meetings can be scheduled by contacting Giorgia Pigato here at Noble Capital Markets.
About Noble Capital Markets, Inc.
Noble Capital Markets is a research-driven investment bank that has supported small and microcap companies since 1984. As a FINRA and SEC licensed broker dealer, Noble provides institutional-quality equity research, merchant and investment banking, and order execution services. In 2018, Noble launched Channelchek—an investor community dedicated exclusively to public small and micro-cap companies and their industries. Channelchek is the first service to offer investors free institutional-quality research without a subscription.
About Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company that addresses significant unmet needs by developing innovative antiviral treatments for challenging diseases including influenza, viral gastroenteritis, COVID, and hepatitis. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs.
Contact:
Alliance Advisors IR
Jody Cain
310-691-7100
jcain@allianceadvisors.com
# # #
FAQ
When is Cocrystal Pharma (COCP) presenting at the Noble Capital Markets Conference?
Who will be presenting for Cocrystal Pharma (COCP) at the Noble Conference?
How can investors access Cocrystal Pharma's (COCP) Noble Conference presentation?
Can investors meet with Cocrystal Pharma's (COCP) management at the Noble Conference?
